Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension

Journal of Hypertension

Volumn 27, Issue SUPPL. 6, 2009, Pages

  Vranková, Stanislava ^a   Jendekova, Lydia ^a   Paulis, Ludovit ^a,b   Sladkova, Martina ^a   Simko, Fedor ^b   Pechanova, Olga ^a,c  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Captopril; Cardiac hypertrophy; Indapamide; Nitric oxide; Spontaneous hypertension

Indexed keywords

ACETYLCHOLINE; ALKADIENE; ANTIOXIDANT; CAPTOPRIL; CONJUGATED DIENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDAPAMIDE; ISOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMORAL ARTERY; HEART LEFT VENTRICLE HYPERTROPHY; KIDNEY; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; TREATMENT RESPONSE; VASODILATATION;

EID: 70349287853     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000358837.64052.0a     Document Type: Article

References (26)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223. (Pubitemid 40138015)
2. Laurent S. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension. J Hypertens 2001; 19 (Suppf. 4): S9-S14. (Pubitemid 33753143)
3. Meyrier A, Dratwa M, Sennesael J, Lachaud-Pettiti V. Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure. Am J Hypertens 1998; 11:1087-1092. (Pubitemid 28451913)
4. De Luca N, Safar M, on behalf of the International Coordination Group. Efficacy of a very low-dose Perindopril 2 mg/indapamide 0.625 mg on cardiac hypertrophy in hypertensive patients: the REASON project. J Hypertens 2002; 20 (Suppl. 4):S164.
5. Luccioni R, Sever PS, Di Perri T, Redon J, Laurandin I, Brault Y, et al. An equivalence study of the safety and efficacy of a fixed-dose combination of Perindopril with indapamide versus fixed-dose combinations of Captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. J Hypertens 1995; 13:1847-1851. (Pubitemid 26015830)
6. Asmar RG, London GM, O'Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38:922-926.
7. Dahlöf B, Gosse P, Guéret P, Dubourg O, de Simone G, Schmieder R, et al., the PICXEL Investigators. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005; 23:2063-2070.
8. Chaffman M, Heel RC, Brogden RN, Speight TM, Avery GS. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drags 1984; 28:189-235.
9. Uehara Y, Shirahase H, Nagata T, lshimitsu T, Morishita S, Osumi S, et al. Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension 1990; 15:216-224.
10. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 1997; 29:235-241. (Pubitemid 27074049)
11. Pecháňová O, Bernatova I, Pelouch V, Simko F. Protein remodelling of the heart in NO-deficient hypertension: the effect of Captopril. J Mol Cell Cardiol 1997; 29:3365-3374. (Pubitemid 28039370)
12. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC. Effects of Captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 2005; 46:943-947.
13. Konstam MA, Patten RD, Thomas I, Ramahi T, La Bresh K, Goldman S, et al. Effects of losartan and captoprilon left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy. Am Heart J 2000; 139:1081-1087. (Pubitemid 30390340)
14. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990; 16:532-540. (Pubitemid 20368342)
15. Kojšová S, Jendeková L, Zicha J, Kuneš J, Andriantsitohaina R, Pecháňová O. The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 2006; 55 (Suppl. 1):S3-S16.
16. Pecháňová O. Contribution of Captopril thiol group to the prevention of spontaneous hypertension. Physiol Res 2007; 56 (Suppl. 2):S41-S48.
17. De Nigris F, D'Armiento FP, Somma P, Casini A, Andreini I, Sarlo F, et al. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. Int J Cardiol 2001; 81:107-116. (Pubitemid 34017424)
18. Männistö TK, Karvonen KE, Kerola TV, Ryhänen LJ. Inhibitory effect of the angiotensin converting enzyme inhibitors Captopril and enalapril on the conversion of procollagen to collagen. J Hypertens 2001 ; 19:1835-1839.
19. Hayek T, Attias J, Smith J, Breslow JL, Keidar S. Antiatherosclerotic and antioxidative effects of Captopril in apolipoprotein E deficient mice. J Cardiovasc Pharmacol 1998; 31:540-544. (Pubitemid 28153130)
20. Pecháňová O, Matušková J, Capiková D, Jendeková L, Paulis L, Šimko F. Effect of Spironolactone and Captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int 2006; 70:170-176. (Pubitemid 44000135)
21. Sihm I, Schroeder AP, Aalkjaer C, Holm M, Morn B, Mulvany M, et al. The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension. Am J Hypertens 1995; 8:987-996.
22. Benetos A, Bouaziz H, Albaladejo P, Guez D, Safar ME. Carotid artery mechanical properties of Dahl salt-sensitive rats. Hypertension 1995; 25:272-277.
23. Qadri F, Arens T, Schwartz EC, Häuser W, Dominiak P. Angiotensinconverting enzyme inhibitors and AT1 -receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats. Jpn J Pharmacol 2001; 85:365-369. (Pubitemid 32421726)
24. Biagini G, Zoli M, Torri C, Boshi S, Vantaggiato G, Ballestri M, et al. Protective effects of delapril, Indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a highsodium diet. Clin Sci 1997; 93:401-411. (Pubitemid 27489935)
25. Garcia-Estan J, Ortiz MC, O'valle F, Alcaraz A, Navarro EG, Vargas F, et al. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitricoxide-deficiencyinduced hypertension in rats. Clin Sci 2006; 110:227-233. (Pubitemid 43241484)
26. Hayakawa H, Coffee K, Raij L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation 1997; 96:2407-2413. (Pubitemid 27425849)